In vitro and in vivo antimicrobial action of tea: The commonest beverage of asia

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 11, 2005, Pages 2125-2127

  Bandyopadhyay, Durba ^a   Chatterjee, Tapan Kumar ^a   Dasgupta, Asish ^a   Lourduraja, Jeyaseeli ^a   Dastidar, Sujata Ghosh ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Antimicrobial activity; Camellia sinensis; Decaffeinated tea extract; In vitro; in vivo; Tea as antimicrobic

Indexed keywords

CAMELLIA SINENSIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASIA; BACILLUS; BACTERIAL STRAIN; BACTERIUM; BEVERAGE; CHI SQUARE TEST; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA; MALE; MOUSE; NONHUMAN; PLANT LEAF; PROTECTION; PSEUDOMONAS AERUGINOSA; SALMONELLA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SHIGELLA; STAPHYLOCOCCUS AUREUS; TEA; VIBRIO CHOLERAE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; COLONY COUNT, MICROBIAL; CULTURE MEDIA; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MALE; MICE; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TEA;

EID: 27744468011     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.28.2125     Document Type: Article

References (16)

1. Nagamori M. H., Okai Y., J. UOEH, 23, 335-344 (2001).
2. Gupta S., Ahmad N., Mohan R. R., Husain M. M., Mukhtar H., Cancer Res., 59, 2115-2120 (1999).
3. Hirose M., Hoshiya T., Akagi K., Futakuchi M., Ito N., Cancer Lett., 83, 149-156 (1994).
4. Yang T. T., Koo M. W., Life Sci., 66, 411-423 (2000).
5. Yang T. T., Koo M. W., Pharmacol. Res., 35, 505-512 (1997).
6. Muramatsu K., Fukuyo M., Hara Y., J. Nutr. Sci. Vitaminol. (Tokyo), 32, 613-622 (1986).
7. Hasegawa R., Chujo T., Sai-Kato K., Umemura T., Tanimura A., Kurokawa Y., Food Chem. Toxicol., 33, 961-970 (1995).
8. Saldana M. D. A., Mohamed R. S., Mazzfera P., Braz. J. Chem. Eng. (Sao Paulo), 17, 251-260 (2000).
9. Peker H., Srinivasan M. P., Smith J. M., McCoy B. J., AIChE J., 38, 761-769 (1992).
10. Barrow G. I., Feltham R. K. A., "Cowan and Steel's Manual for the Identification of Medical Bacteria," Cambridge University Press, Cambridge, U. K., 1993, pp. 50-164.
11. National Committee for Clinical Laboratory Standards, "Methods for Dilution in Antimicrobial Susceptibility Tests," Approved Standard M2-A5. NCCLS, Villanova, PA, 1993.
12. Cruickshank R., Duguid J. P., Marmion B. P., Swain R. H. A. (ed.),"Biological Standardization," Medical Microbiology, Vol. 2, 12th ed., Churchill Livingstone, London, 1975, p. 314.
13. Kawase M., Motohashi N., Debnath S., Mahapatra S., Dastidar S. G., Chakrabarty A. N., Arzneim.-Forsch./Drug Res., 51, 67-71 (2000).
14. Shirataki Y., Motohashi N., Tani S., Sakagami H., Satoh K., Nakashima H., Mahapatra S. K., Ganguly K., Dastidar S. G., Chakrabarty A. N., Anticancer Res., 21, 275-280 (2001).
15. Dastidar S. G., Mahapatra S. K., Ganguly K., Chakrabarty A. N., In Vivo, 15, 519-524 (2001).
16. Mazumder R., Dastidar S. G., Basu S. P., Mazumder A., Kumar S., Ancient Science of Life, 22, 160-165 (2003).